 |
|
MicroRNAs in Blood May be Biomarkers of Pancreatic Cancer
(Posted: 09/01/2009) - Small molecules known as microRNAs, which can be detected in blood samples, have the potential to help identify patients with pancreatic cancer, a study finds. The study, by researchers at The University of Texas M.D. Anderson Cancer Center in Houston, was supported by the Early Detection Research Network (EDRN) of the National Cancer Institute (NCI), part of the National Institutes of Health.
NIH Study Reveals New Genetic Culprit in Deadly Skin Cancer
(Posted: 08/31/2009) - Drawing on the power of DNA sequencing, National Institutes of Health researchers have identified a new group of genetic mutations involved in the deadliest form of skin cancer, melanoma. This discovery is particularly encouraging because some of the mutations, which were found in nearly one-fifth of melanoma cases, reside in a gene already targeted by a drug approved for certain types of breast cancer.
Hormone Cycling Found to Affect Gene Activity
(Posted: 08/16/2009) - Intermittent signaling by steroid hormones can affect the way genes are expressed in rodents, according to research by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, and the Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, Bristol, England.
Risk of Pancreatic Cancer Linked to Variation in Gene that Determines Blood Type
(Posted: 08/02/2009) - Common variants of the gene that determines human blood type are associated with an increased risk of pancreatic cancer, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, and colleagues from many universities and research institutions. The study, published online Aug. 2, 2009, in Nature Genetics, is consistent with an observation first made more than 50 years ago.
< Previous 1 2 3
 View Archive of News Releases
|
|
|
